The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Suiseng Coli /C Suspension for injection for pigs

. Suspension for injection

Laboratorios Hipra S.A.VPA10846/019/001

Main Information

Trade NameSuiseng Coli /C Suspension for injection for pigs
Active SubstancesF4ab fimbrial adhesin of e.coli
F4ac fimbrial adhesin of e.coli
F5 fimbrial adhesin of e.coli
F6 fimbrial adhesin of e. coli
Lt enterotoxoid of e. coli
Clostridium perfringens, type C toxoid
Clostridium novyi, type B toxoid
Dosage FormSuspension for injection
Licence HolderLaboratorios Hipra S.A.
Licence NumberVPA10846/019/001

Group Information

ATC CodeQI09AB08 escherichia + clostridium
Therapeutic ClassImmunological


Licence Issued26/07/2019
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back